J&J | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Abbott USD 25.02B 408M 2024-09
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Baxter International USD 683M 0 2024-12
Bayer EUR 2.52B 0 2024-12
Becton, Dickinson and Co. USD 371M 0 2024-12
Biogen USD 100K 0 2024-12
Boston Scientific USD 17M 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
CONMED USD 313K 0 2024-12
Cooper Companies USD 21.7M 0 2024-10
Dexcom USD 400K 0 2024-12
Edwards Lifesciences USD 654.8M 500K 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Globus Medical USD 137K 2K 2024-12
Hologic USD 3M 0 2024-12
Indivior 65M 2M 2024-09
Insulet USD 100K 0 2024-12
Integra LifeSciences USD 916K 0 2024-12
Intuitive Surgical USD 400K 0 2024-09
J&J USD 3.12B 0 2024-12
Medtronic USD 0 128K 2025-01
Merck USD 1.79B 0 2024-12
Merit Medical Systems USD 703.22M 34.01M 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
Stryker USD 38M 0 2024-12
Tandem Diabetes Care USD 66K 0 2024-12
Teva Pharmaceutical Industries USD 58M 0 2024-09
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Zimmer Biomet Holdings USD 3.2M 0 2024-12
Zoetis USD 5M 0 2024-12



J&J Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.